SF-1, SF-2, SF-2, SF-2, Fugong, Gongjin stickers and blue boxes and other products, the main role of the product is to treat cervical diseases, repair and healing of cervical wounds. SF-1, SF-2, SF-2, SF-2, Fugong, Gongjin stickers and blue boxes and other products, the main role of the product is to treat cervical diseases, repair and healing of cervical wounds.
Shifute skin antibacterial agent, Shifushumi biological antibacterial care solution and Shumi youth source. Product function and wound healing, anti-inflammatory, antibacterial, anti-viral. Shifute skin antibacterial agent, Shifushumi biological antibacterial care solution and Shumi youth source. Product function and wound healing, anti-inflammatory, antibacterial, anti-viral.
Biskelly Herbal Antibacterial Gel, Chudie, Thistle Man Antibacterial Liquid, Ningduo Herbal Antibacterial Capsule 1, Ningduo Herbal Antibacterial Capsule 2, Ningduo Herbal Antibacterial Capsule 3 and Xinjiang Guli Press Baier The treasure of youth. Biskelly Herbal Antibacterial Gel, Chudie, Thistle Man Antibacterial Liquid, Ningduo Herbal Antibacterial Capsule 1, Ningduo Herbal Antibacterial Capsule 2, Ningduo Herbal Antibacterial Capsule 3 and Xinjiang Guli Press Baier The treasure of youth.
The world's leading low-temperature freeze-drying process creates the product's strong adsorption.
Unique shape and novel design
It conforms to the female cervical physiology.
The special combination ingredient "shell iodine" is used for sustained treatment and targeted release.
The only “(?)therapeutic”(?) diaphragm developed independently in China is the first pad-based moisturizing therapy.
Non-surgical and non-antibiotic treatments are safe, non-toxic and without side effects.
The product has good biocompatibility with the human body and can be degraded completely without taking out.
On the 3rd, the US FDA announced the approval of the listing of the CD38 antibody Sarclisa (isatuximab-irfc) developed by Sanofi (Sanofi) for use in combination with pomalidomide and dexamethasone to
Read More With the continuous improvement of the medical security level of more than 1.3 billion people, my country's biomedical industry has huge market space. Compared with advanced countries in the world
Read More The newly revised "Regulations for the Supervision and Administration of Medical Devices" (hereinafter referred to as the "Regulations") have been implemented since June 1, 2014. I
Read More Editor's note: Recently, the National Health Commission responded to Recommendation No. 6238 of the First Session of the 13th National People's Congress. The reply stated that the National Hea
Read More